Egyptian cobra venom toxins (NhV) (NhV)

The venom toxins from Naja haje, commonly known as the Egyptian cobra, consist of a sophisticated mixture of proteins designed for prey immobilization and defense. The most significant components are the three-finger toxins (3FTx), particularly alpha-neurotoxins, which exhibit high affinity for nicotinic acetylcholine receptors at the neuromuscular junction, resulting in post-synaptic blockade and subsequent respiratory paralysis (UniProt, 2023). Beyond neurotoxicity, the venom contains cytotoxins that cause membrane disruption and localized tissue damage, as well as phospholipase A2 enzymes that mediate inflammatory responses and enzymatic degradation of phospholipids (PubMed, 2022). In medical practice, these toxins are the direct targets of antivenom therapy, where equine or ovine-derived antibodies are used to neutralize the venom's lethal effects (WHO, 2024). While the venom itself is a lethal cocktail, individual components are researched for potential therapeutic applications in pain management and anticoagulation due to their high specificity for ion channels and receptors (NIH, 2021).

Other names

Naja haje venomEgyptian cobra toxinsAsp venom

Antivenom antibodies bind to and sequester venom toxins, preventing their interaction with physiological targets such as nicotinic acetylcholine receptors and cell membranes (WHO, 2024).